ATE344248T1 - Antibakterielle verbindungen - Google Patents
Antibakterielle verbindungenInfo
- Publication number
- ATE344248T1 ATE344248T1 AT00932760T AT00932760T ATE344248T1 AT E344248 T1 ATE344248 T1 AT E344248T1 AT 00932760 T AT00932760 T AT 00932760T AT 00932760 T AT00932760 T AT 00932760T AT E344248 T1 ATE344248 T1 AT E344248T1
- Authority
- AT
- Austria
- Prior art keywords
- antibacterial compounds
- antibacterial
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13594899P | 1999-05-25 | 1999-05-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE344248T1 true ATE344248T1 (de) | 2006-11-15 |
Family
ID=22470518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00932760T ATE344248T1 (de) | 1999-05-25 | 2000-05-24 | Antibakterielle verbindungen |
Country Status (9)
Country | Link |
---|---|
US (2) | US6559172B1 (de) |
EP (1) | EP1194144B1 (de) |
JP (1) | JP4948708B2 (de) |
AR (1) | AR024077A1 (de) |
AT (1) | ATE344248T1 (de) |
AU (1) | AU5043500A (de) |
CO (1) | CO5170486A1 (de) |
DE (1) | DE60031682T2 (de) |
WO (1) | WO2000071120A1 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO5180550A1 (es) | 1999-04-19 | 2002-07-30 | Smithkline Beecham Corp | Inhibidores de fab i |
CO5370679A1 (es) | 1999-06-01 | 2004-02-27 | Smithkline Beecham Corp | Inhibidores fab 1 |
US6762201B1 (en) | 1999-10-08 | 2004-07-13 | Affinium Pharmaceuticals, Inc. | Fab I inhibitors |
AU773218B2 (en) * | 1999-10-08 | 2004-05-20 | Debiopharm International Sa | Fab I inhibitors |
US6730684B1 (en) * | 1999-10-08 | 2004-05-04 | Affinium Pharmaceuticals, Inc. | Fab I inhibitors |
DE60230934D1 (de) * | 2001-04-06 | 2009-03-05 | Affinium Pharm Inc | Fab-i-inhibitoren |
FR2825926A1 (fr) * | 2001-06-14 | 2002-12-20 | Sod Conseils Rech Applic | Derives d'imidazoles modulant les canaux sodiques |
WO2003022820A1 (en) * | 2001-09-06 | 2003-03-20 | Bristol-Myers Squibb Pharma Company. | Heteroaromatic substituted cyclopropane as corticotropin releasing hormone |
JP4859460B2 (ja) * | 2002-12-06 | 2012-01-25 | アフィニウム ファーマシューティカルズ, インク. | ヘテロ環化合物、その製造方法および治療におけるその使用 |
CN1747936A (zh) * | 2003-02-12 | 2006-03-15 | 特兰斯泰克制药公司 | 作为治疗试剂的取代吡咯衍生物 |
CA2519429C (en) * | 2003-03-17 | 2013-08-06 | Affinium Pharmaceuticals, Inc. | Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics |
ZA200605526B (en) * | 2004-02-12 | 2007-11-28 | Transtech Pharma Inc | Substituted azole derivatives, compositions and methods of use |
WO2007053131A2 (en) * | 2004-06-04 | 2007-05-10 | Affinium Pharmaceuticals, Inc. | Acrylamide derivatives as antibiotic agents |
WO2006092059A1 (en) * | 2005-03-04 | 2006-09-08 | Fan Wu | Design and synthesis of novel antimicrobials |
CA2632476A1 (en) * | 2005-12-05 | 2007-06-14 | Affinium Pharmaceuticals, Inc. | Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
CA2637312A1 (en) * | 2006-01-27 | 2007-08-02 | F. Hoffmann-La Roche Ag | Use of substituted 2-imidazole of imidazoline derivatives |
CA2658506C (en) | 2006-07-20 | 2016-01-26 | Affinium Pharmaceuticals, Inc. | Acrylamide derivatives as fab 1 inhibitors |
CA2664794A1 (en) * | 2006-10-20 | 2008-05-02 | Merck & Co., Inc. | Substituted imidazoles as bombesin receptor subtype-3 modulators |
JP2010506917A (ja) * | 2006-10-20 | 2010-03-04 | メルク エンド カムパニー インコーポレーテッド | ボンベシンレセプターサブタイプ3モジュレーターとしての置換イミダゾール |
RU2009118935A (ru) * | 2006-10-20 | 2010-11-27 | Мерк энд Ко., Инк. (US) | Земещенные имидазолы в качестве модуляторов подтипа 3 бомбезиновых рецепторов |
WO2008098374A1 (en) * | 2007-02-16 | 2008-08-21 | Affinium Pharmaceuticals, Inc. | Salts, prodrugs and polymorphs of fab i inhibitors |
JP5313044B2 (ja) * | 2008-08-08 | 2013-10-09 | 四国化成工業株式会社 | 銅または銅合金の表面処理剤及びその利用 |
JP5301218B2 (ja) * | 2008-08-25 | 2013-09-25 | 四国化成工業株式会社 | 銅または銅合金の表面処理剤及びその利用 |
JP5484795B2 (ja) * | 2008-09-03 | 2014-05-07 | 四国化成工業株式会社 | 2−ベンジル−4−(3,4−ジクロロフェニル)−5−メチルイミダゾール化合物 |
JP5260367B2 (ja) * | 2008-09-26 | 2013-08-14 | 四国化成工業株式会社 | 2−(クロロベンジル)−4−フェニルイミダゾール化合物 |
CN102171382B (zh) * | 2008-10-06 | 2013-08-14 | 四国化成工业株式会社 | 2-苄基-4-(2,4-二氯苯基)-5-甲基咪唑化合物 |
JP5368244B2 (ja) * | 2009-10-14 | 2013-12-18 | 四国化成工業株式会社 | 2−(2,4−ジクロロベンジル)−4−アリール−5−メチルイミダゾール化合物 |
JP5368263B2 (ja) * | 2009-11-04 | 2013-12-18 | 四国化成工業株式会社 | 4−(2,4−ジクロロフェニル)−5−メチルイミダゾール化合物 |
JP5368271B2 (ja) * | 2009-11-20 | 2013-12-18 | 四国化成工業株式会社 | 4−(4−ビフェニリル)−2−(2,4−ジクロロベンジル)イミダゾールおよび表面処理液 |
JP5398076B2 (ja) * | 2009-12-10 | 2014-01-29 | 四国化成工業株式会社 | 2−(ブロモベンジル)−4−(ブロモフェニル)−5−メチルイミダゾール化合物 |
JP5398075B2 (ja) * | 2010-01-13 | 2014-01-29 | 四国化成工業株式会社 | 4−(ジクロロフェニル)−2−(4−フルオロベンジル)−5−メチルイミダゾール化合物 |
JP5615227B2 (ja) * | 2011-05-23 | 2014-10-29 | 四国化成工業株式会社 | 銅または銅合金の表面処理剤及びその利用 |
JP5615233B2 (ja) | 2011-06-20 | 2014-10-29 | 四国化成工業株式会社 | 銅または銅合金の表面処理剤及びその利用 |
WO2013190384A1 (en) | 2012-06-19 | 2013-12-27 | Affinium Pharmaceuticals, Inc. | Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
JP5892605B2 (ja) * | 2012-08-17 | 2016-03-23 | 四国化成工業株式会社 | 4−(2−チエニル)イミダゾール化合物 |
MX2018010254A (es) | 2016-02-26 | 2018-12-19 | Debiopharm Int Sa | Medicamento para el tratamiento de infecciones de pie diabetico. |
IL301709A (en) | 2017-08-09 | 2023-05-01 | Denali Therapeutics Inc | Compounds, preparations and methods |
WO2019152977A2 (en) | 2018-02-05 | 2019-08-08 | Bio-Rad Laboratories, Inc. | Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand |
CR20210426A (es) | 2019-02-13 | 2021-09-30 | Denali Therapeutics Inc | Compuestos, composiciones y métodos |
US20220177456A1 (en) * | 2019-03-06 | 2022-06-09 | Denali Therapeutics Inc. | Compounds, compositions and methods |
JP7479686B2 (ja) | 2020-10-16 | 2024-05-09 | 株式会社岩や | 壁パネル |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3657441A (en) | 1970-07-30 | 1972-04-18 | Merck & Co Inc | Method of inhibiting the formation of phenylethanolamine n-methyl transferase with imidazoles |
FR2122395A1 (en) * | 1971-01-19 | 1972-09-01 | Berlin Chemie Veb | Pharmacologically active imidazoles - by condensing alpha-aminoketones with formamide |
US4218458A (en) | 1978-06-23 | 1980-08-19 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
FR2482859A1 (fr) * | 1980-05-22 | 1981-11-27 | Fabre Sa Pierre | Fluorhydrates d'heterocycles azotes insatures utilisables en therapeutique dentaire |
DE4015535A1 (de) * | 1990-05-15 | 1991-11-21 | Basf Ag | Verfahren zur herstellung von n-substituierten imidazolen |
CA2106337C (en) * | 1992-09-26 | 1998-06-16 | Hiroyuki Nakanishi | Phenylimidazole derivatives, processes for production thereof, herbicides comprising said derivatives, and usages of said herbicides |
JP3311858B2 (ja) * | 1994-03-08 | 2002-08-05 | 四国化成工業株式会社 | 銅及び銅合金の表面処理剤 |
JPH10280162A (ja) * | 1997-04-07 | 1998-10-20 | Hideaki Yamaguchi | プリント配線板の表面保護剤および表面保護膜の形成方法。 |
US6121260A (en) * | 1997-07-03 | 2000-09-19 | Neurogen Corporation | Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives |
-
2000
- 2000-05-23 AR ARP000102517A patent/AR024077A1/es unknown
- 2000-05-24 EP EP00932760A patent/EP1194144B1/de not_active Expired - Lifetime
- 2000-05-24 AT AT00932760T patent/ATE344248T1/de not_active IP Right Cessation
- 2000-05-24 JP JP2000619427A patent/JP4948708B2/ja not_active Expired - Fee Related
- 2000-05-24 US US09/979,560 patent/US6559172B1/en not_active Expired - Fee Related
- 2000-05-24 WO PCT/US2000/014330 patent/WO2000071120A1/en active IP Right Grant
- 2000-05-24 AU AU50435/00A patent/AU5043500A/en not_active Abandoned
- 2000-05-24 CO CO00038198A patent/CO5170486A1/es not_active Application Discontinuation
- 2000-05-24 DE DE60031682T patent/DE60031682T2/de not_active Expired - Lifetime
-
2003
- 2003-01-09 US US10/339,092 patent/US6673941B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2003500357A (ja) | 2003-01-07 |
AU5043500A (en) | 2000-12-12 |
US20030149089A1 (en) | 2003-08-07 |
JP4948708B2 (ja) | 2012-06-06 |
EP1194144A1 (de) | 2002-04-10 |
US6673941B2 (en) | 2004-01-06 |
AR024077A1 (es) | 2002-09-04 |
DE60031682D1 (de) | 2006-12-14 |
CO5170486A1 (es) | 2002-06-27 |
EP1194144B1 (de) | 2006-11-02 |
WO2000071120A1 (en) | 2000-11-30 |
DE60031682T2 (de) | 2007-09-06 |
US6559172B1 (en) | 2003-05-06 |
EP1194144A4 (de) | 2002-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE344248T1 (de) | Antibakterielle verbindungen | |
ATE283049T1 (de) | Antibakterielle verbindungen | |
EE200100502A (et) | Ühendid | |
ATE283845T1 (de) | Pyrimidinon verbindungen | |
DE60031481T8 (de) | Polymer-gebundene funktionelle Verbindungen | |
DE60210782D1 (de) | Glukokinase beeinflussende verbindungen | |
EE200200224A (et) | Uudsed ühendid | |
DE50004593D1 (de) | Formmassen | |
DE69939378D1 (de) | Antithrombotische verbindungen | |
ATE258921T1 (de) | Aryl-annellierte azapolycyclische verbindungen | |
NO20020621D0 (no) | Antibakterielle midler | |
NO20013769L (no) | Kalsilytiske forbindelser | |
NO20020466D0 (no) | Kalsilytiske forbindelser | |
DE60228478D1 (de) | Aryl-annellierte azapolyzyklische verbindungen | |
NO20014262D0 (no) | Tiazoloindolinon-forbindelser | |
ID29984A (id) | Senyawa-senyawa bis-stirilbifenil | |
SE9901118D0 (sv) | Novel compounds | |
SE9901271D0 (sv) | Novel compounds | |
SE9901117D0 (sv) | Novel compounds | |
SE9901078D0 (sv) | Novel compounds | |
SE9902194D0 (sv) | Novel compounds | |
SE9904651D0 (sv) | Novel compounds | |
SE9903838D0 (sv) | Novel compounds | |
SE9903080D0 (sv) | Novel compounds | |
SE9902903D0 (sv) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |